Cargando…
The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice
OBJECTIVE: Adverse metabolic changes associated with loss of ovarian function increase the risk of developing metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. Naringenin improves metabolic disturbances in vitro and in vivo. In the present study, we tested the...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350282/ https://www.ncbi.nlm.nih.gov/pubmed/25745505 http://dx.doi.org/10.1186/1743-7075-12-1 |
_version_ | 1782360164825825280 |
---|---|
author | Ke, Jia-Yu Kliewer, Kara L Hamad, Essam M Cole, Rachel M Powell, Kimerly A Andridge, Rebecca R Straka, Shana R Yee, Lisa D Belury, Martha A |
author_facet | Ke, Jia-Yu Kliewer, Kara L Hamad, Essam M Cole, Rachel M Powell, Kimerly A Andridge, Rebecca R Straka, Shana R Yee, Lisa D Belury, Martha A |
author_sort | Ke, Jia-Yu |
collection | PubMed |
description | OBJECTIVE: Adverse metabolic changes associated with loss of ovarian function increase the risk of developing metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. Naringenin improves metabolic disturbances in vitro and in vivo. In the present study, we tested the effects of naringenin on metabolic disturbances resulting from estrogen deficiency in ovariectomized mice. MATERIALS/METHODS: Ovariectomized C57BL/6 J female mice were fed a control diet (10% calories from fat) for 11 weeks. Mice either continued on the control diet (n = 9) or were switched to the control diet supplemented with 3% naringenin (n = 10) for the next 11 weeks. Energy expenditure was measured by indirect calorimetry and activity was monitored by infrared beam breaks. Intra-abdominal and subcutaneous adiposity was evaluated by magnetic resonance imaging (MRI). Blood biochemical measures of metabolic response included glucose, insulin, adipokines, and lipids. Lipid content in liver and muscle and expression of relevant genes in adipose tissue, liver, and muscle were quantified. RESULTS: Ovariectomized mice fed naringenin exhibited lower fasting glucose and insulin levels compared to controls, with over 50% reduction of intra-abdominal and subcutaneous adiposity. Plasma leptin and leptin mRNA in adipose depots were also decreased in mice fed a naringenin diet. Monocyte chemoattractant protein-1 (MCP1/Ccl2) and interleukin 6 (IL-6/Il6) mRNA expression levels were significantly lower in perigonadal adipose tissue of naringenin-supplemented mice. We also observed that mice fed a naringenin diet had less hepatic lipid accumulation with corresponding alterations of hepatic gene expression associated with de novo lipogenesis, fatty acid oxidation, and gluconeogenesis. CONCLUSION: Dietary naringenin attenuates many of the metabolic disturbances associated with ovariectomy in female mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-7075-12-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4350282 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43502822015-03-06 The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice Ke, Jia-Yu Kliewer, Kara L Hamad, Essam M Cole, Rachel M Powell, Kimerly A Andridge, Rebecca R Straka, Shana R Yee, Lisa D Belury, Martha A Nutr Metab (Lond) Research OBJECTIVE: Adverse metabolic changes associated with loss of ovarian function increase the risk of developing metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. Naringenin improves metabolic disturbances in vitro and in vivo. In the present study, we tested the effects of naringenin on metabolic disturbances resulting from estrogen deficiency in ovariectomized mice. MATERIALS/METHODS: Ovariectomized C57BL/6 J female mice were fed a control diet (10% calories from fat) for 11 weeks. Mice either continued on the control diet (n = 9) or were switched to the control diet supplemented with 3% naringenin (n = 10) for the next 11 weeks. Energy expenditure was measured by indirect calorimetry and activity was monitored by infrared beam breaks. Intra-abdominal and subcutaneous adiposity was evaluated by magnetic resonance imaging (MRI). Blood biochemical measures of metabolic response included glucose, insulin, adipokines, and lipids. Lipid content in liver and muscle and expression of relevant genes in adipose tissue, liver, and muscle were quantified. RESULTS: Ovariectomized mice fed naringenin exhibited lower fasting glucose and insulin levels compared to controls, with over 50% reduction of intra-abdominal and subcutaneous adiposity. Plasma leptin and leptin mRNA in adipose depots were also decreased in mice fed a naringenin diet. Monocyte chemoattractant protein-1 (MCP1/Ccl2) and interleukin 6 (IL-6/Il6) mRNA expression levels were significantly lower in perigonadal adipose tissue of naringenin-supplemented mice. We also observed that mice fed a naringenin diet had less hepatic lipid accumulation with corresponding alterations of hepatic gene expression associated with de novo lipogenesis, fatty acid oxidation, and gluconeogenesis. CONCLUSION: Dietary naringenin attenuates many of the metabolic disturbances associated with ovariectomy in female mice. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1743-7075-12-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-01-13 /pmc/articles/PMC4350282/ /pubmed/25745505 http://dx.doi.org/10.1186/1743-7075-12-1 Text en © Ke et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Ke, Jia-Yu Kliewer, Kara L Hamad, Essam M Cole, Rachel M Powell, Kimerly A Andridge, Rebecca R Straka, Shana R Yee, Lisa D Belury, Martha A The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice |
title | The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice |
title_full | The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice |
title_fullStr | The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice |
title_full_unstemmed | The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice |
title_short | The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice |
title_sort | flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350282/ https://www.ncbi.nlm.nih.gov/pubmed/25745505 http://dx.doi.org/10.1186/1743-7075-12-1 |
work_keys_str_mv | AT kejiayu theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT kliewerkaral theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT hamadessamm theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT colerachelm theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT powellkimerlya theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT andridgerebeccar theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT strakashanar theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT yeelisad theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT belurymarthaa theflavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT kejiayu flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT kliewerkaral flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT hamadessamm flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT colerachelm flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT powellkimerlya flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT andridgerebeccar flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT strakashanar flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT yeelisad flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice AT belurymarthaa flavonoidnaringenindecreasesadiposetissuemassandattenuatesovariectomyassociatedmetabolicdisturbancesinmice |